The development and maintenance of the prostate is dependent on androgens and the androgen receptor. The androgen pathway continues to be important in prostate cancer. Here, we evaluated the transcriptome of prostate cancer cells in response to androgen using long serial analysis of gene expression (LongSAGE) libraries.
Background
Androgens mediate their effect through the androgen receptor (AR) and together they play integral roles in the development and maintenance of the prostate. In the absence of a functional androgen-axis during development, the prostate will fail to form [1] . The size of the pros-tate increases with the elevation of levels of androgens in males during puberty [2] . Androgens promote proliferation, differentiation, and survival of prostate cells [1] . Men that have used excess androgens in the form of anabolic steroids have a higher incidence of prostate cancer [3] [4] [5] . Association of prostate cancer with levels of androgens has also been reported in rodents [6, 7] . Reduction of androgen in humans or dogs before puberty by castration is associated with decreased incidence of prostate cancer [8, 9] . Castration of adult males causes apoptosis of prostatic epithelium, involution and reduction of the prostate [10] [11] [12] . Thus the prostate gland is an androgendependent organ where androgens are the predominant mitogenic stimulus [13] . The dependency of the prostate epithelium on androgens provides the underlying rationale for treating prostate cancer with chemical or surgical castration (androgen-deprivation) [14] .
The AR is a ligand-activated transcription factor [15] that regulates transcription of genes that contain androgen response elements (AREs) in the upstream or downstream regulatory regions of the promoter and/or enhancer. Kallikrein 3 (KLK3) is an example of a gene that contains numerous functional AREs that the AR interacts with to increase transcription in response to androgens [16] [17] [18] [19] . KLK3, also known as prostate-specific antigen (PSA), is the main tumor marker for prostate cancer and has been used clinically for 15 years [20] . Serum levels of PSA correlate with tumor volume [21] . However, as a screening and monitoring tool for prostate cancer, serum PSA levels are subject to false positives and false negatives [20] .
Identification of the genes that change in expression in response to androgen in prostate cells is essential for the understanding of androgen-dependency of the normal prostate and the proliferation, survival, and hormonal progression of prostate cancer. There are several studies that have investigated genes that alter expression in response to a changing androgen-axis using SAGE [22] [23] [24] . Here we highlight several key differences in the current experimental design from previous studies: 1) a physiological concentration of metabolically stable androgen (R1881) was employed in vitro; 2) the transcriptome was catalogued using LongSAGE [25] opposed to (short)SAGE [26] because it generates lengthier tags allowing increased confidence in tag-to-gene mapping, and leaves fewer tags unmapped [25] ; 3) the transcriptome of human prostate cancer cells was examined instead of murine cells [22] ; 4) sequencing depth was increased by approximately 1.5-2 times more tags relative to other studies [23, 24] to improve the potential for novel findings; 5) transcript expression was validated using an alternative assay as opposed to protein expression [24] , and tens of novel genes were validated as opposed to only two [23] . Thus, we apply LongSAGE for the first time to create transcript libraries of prostate cancer cells maintained in the presence or absence of androgen. These libraries are publicly available at Gene Expression Omnibus. We describe 24 genes never before identified or validated to alter expression in response to androgen treatment. These genes were: ARL6IP5, BLVRB, C19orf48, C1orf122, C6orf66, CAMK2N1, CCNI, DERA, ERRFI1,  GLUL, GOLPH3, HM13, HSP90B1, MANEA, NANS,  NIPSNAP3A, SLC41A1, SOD1, SVIP, TAOK3, TCP1,  TMEM66 , USP33, and VTA1. Statistically significant changes in expression of ARL6IP5, CAMK2N1, ERRFI1, HSP90B1, and TAOK3 in response to reduced levels of circulating androgens were measured using in vivo samples.
Results and discussion

Summary of LongSAGE libraries
LongSAGE was employed to obtain quantitative gene expression profiles of human prostate cancer cells treated with or without synthetic androgen R1881. LNCaP human prostate cancer cells were chosen as the model cell line for evaluating androgen signaling because they respond to androgens, express a functional although mutated (T877A) AR, they can be grown in vitro as a monolayer or in vivo as a xenograft or in the Hollow Fiber model [27] [28] [29] . LNCaP cells have been used extensively in prostate cancer research. The time of 16 hours for treatment and concentration of R1881 (10 nM) were chosen based upon optimal induction of levels of KLK3 mRNA [30] .
LongSAGE libraries were sequenced to a total of 121,760 (R1881) and 103,391 (vehicle) tags ( Table 1 ). The libraries were filtered on several levels to leave only useful tags for analysis. First, bad tags were removed if they contained at least one N-base call in the LongSAGE tag sequence. Notably, when bad tags were filtered the percentages of duplicate ditags in the R1881 and vehicle LongSAGE libraries were 6% and 5%, respectively. Early SAGE studies suggest duplicate ditags likely represent polymerase chain reaction (PCR) artifacts due to the low probability the same two tags will ligate together to form ditags [26] . However, with LongSAGE library sequencing and highly expressed transcripts, this probability becomes significant [31] . A recent study [32] suggests that discarding duplicate ditags in LongSAGE analysis may introduce a bias affecting the fold differences in tag expression between libraries for all tags observed at a frequency >(113-224)/100,000. Therefore, we opted to retain duplicate ditags. PHRED software was used to call bases for the sequencing of the LongSAGE tags [33, 34] . PHRED has a small, but significant error rate in base-calls. To ascertain which tags potentially contained these erroneous basecalls, we calculated a tag sequence quality factor (QF) and probability [35] . The second line of filtering removed LongSAGE tags with probabilities less than 0.95 (QF < 95%). Linkers of known sequence were introduced into SAGE libraries as primers for amplifying ditags prior to concatenation [26] . These linker sequences were designed so they do not map to the human genome. At a low frequency, linkers ligate to themselves creating linkerderived tags (LDTs). These LDTs do not represent transcripts and are removed from the LongSAGE libraries. After filtering, there were 97,981 total useful tags representing 23,828 tag sequences in the R1881 LongSAGE library, and 85,861 total useful tags representing 24, 592 tag sequences in the vehicle LongSAGE library. Due to redundancy in the expressed sequences, the combined number of useful tag types in the R1881 and vehicle Long-SAGE libraries was 38,574. The remainder of the data analysis in this manuscript was carried out using this filtered data.
Tag frequency and transcript abundance
Tag frequency spanned over three orders of magnitude corresponding to transcript abundance of 5 to 8,746 copies per cell (based on minimum and maximum observed tag counts of 1 and 1714; see Table 2 legend) [36] . The distribution of LongSAGE tag frequencies per 100,000 tags revealed the majority (64 and 67%) of tag types in each LongSAGE library (R1881 and vehicle, respectively) were singletons (tags counted only once). This result was consistent with other published SAGE libraries reporting 66% singletons [37] . Singletons can represent very low abundance transcripts (≤ 5 transcript copies per cell) or PCR/ sequencing errors. Estimates indicate that less than 17% of LongSAGE tags in a library contain PCR/sequencing errors [38] . Coincidently, 17% of the total tags in the R1881 and vehicle LongSAGE libraries roughly equal the number of singletons in each LongSAGE library ( Table 2) . Although initial estimates suggest 6.8-10% of shortSAGE tags contain PCR/sequencing errors, more recent experimental evidence suggests the actual error rate is much lower (≤ 2%) [39] . This implies that an error rate of 17% may also be an overestimate for LongSAGE tags. Tag types counted 2-4 times per 100,000 tags (10-20 transcript cop- ies per cell) and 5-9 times per 100,000 tags (25-45 transcript copies per cell) were the second and third most common groups of tag types, respectively. Generally, high frequency tags were less common. The majority of total tags in each LongSAGE library were derived from a few tag types detected between 10-99 times per 100,000 tags (50-495 transcript copies per cell).
Mapping distribution of LongSAGE tags
When mapped tags (v38 Ensembl) were clustered to amalgamate 1-off tags (see Methods, Gene Expression Analysis for a description) and tags that mapped ambiguously were removed, the tag types in the R1881 and vehicle Long-SAGE libraries represented 7,484 genes and 7,441 genes, respectively ( Table 3 ). Tag types that mapped ambiguously constituted 13% (R1881 and vehicle), while 36% (R1881) and 35% (vehicle) of tag types did not map to the genome (Table 3 ). Due to the fact that these tags were clustered, the majority of the tags that did not map to the genome probably represent true unannotated transcripts rather than PCR/sequencing errors. Approximately 28% of tags in each LongSAGE library mapped to the opposite strand of known genes. These LongSAGE tags either represent transcription from previously undescribed coding regions or true antisense transcripts. Each LongSAGE library contained tags representing transcripts from 32% of the genes in the Ensembl gene database. This percentage is indicative of the depth of coverage of the transcriptome achieved with LongSAGE. Alternatively, this percentage indicates that one third of known Ensembl genes were expressed in LNCaP cells under these experimental conditions. This percentage is substantial when considering tag types from the Mouse Atlas Project (8.55 million total LongSAGE tags generated from 72 libraries of mouse development) mapped to 57% of the Ensembl transcript database [35] . Approximately 63% (R1881) and 61% (vehicle) of the genes that mapped to Ensembl's database were associated with more than one tag type to suggest that most gene expression was represented by transcript variants which is consistent with previous observations [35] . When the mapped LongSAGE tags (Reference Sequence, RefSeq; May 18, 2006) were clustered to amalgamate 1-off tags and tags that mapped ambiguously were removed, 53% of tags mapped solely to known exons, 9% solely to known introns (novel transcript vari-ants), and 38% to intergenic regions (novel genes or transcript variants).
The two most abundant tag types in the LongSAGE libraries were shared by both libraries. The first highly abundant LongSAGE tag mapped to human mitochondrial NADH ubiquinone oxidoreductase chain 4. This gene is also highly expressed in other human tissues (i.e., cardiac tissue; SAGE Genie, http://cgap.nci.nih.gov/SAGE). The protein product of this gene transfers electrons from NADH to ubiquinone to generate adenosine triphosphate as metabolic energy. Using the Ensembl database, the second most abundant LongSAGE tag mapped to a non-coding gene of human mitochondria. In contrast to the higher abundance classes, the lower abundance classes were enriched for LongSAGE tags that mapped to genes with functions in regulating transcription ( Table 2 ). This is particularly significant because the percentages of Long-SAGE tags that mapped to the genome in the lower abundance class were reduced compared to the higher abundance classes ( Table 2 ). Together this implies that the number of tags that map to genes with a function in transcription may be underestimated, as low abundance tags may be underrepresented.
Differential gene expression
Venn analysis identified that 36% and 38% of tag types were exclusive to the R1881 or vehicle LongSAGE libraries, respectively ( Figure 1 ). The unique expression of tag types indicates differential expression depending upon androgen stimulation. The biological relevance of this differential expression is complicated by the fact that 85% (R1881) and 88% (vehicle) of these exclusive LongSAGE tags were singletons. Consistent with our observation that low abundance tags did not map as readily to the genome, the mutually exclusive tags also did not map as readily as tags shared between both libraries. Only 17% and 15% of tags exclusive to R1881 and vehicle LongSAGE libraries, respectively, mapped unambiguously sense to RefSeq, in contrast to 39% of shared tags. We therefore, concentrated on genes for which the tag abundance allowed for the determination of statistically significant changes in transcript abundance. Figure 2 ). 891 tags were differentially expressed (p ≤ 0.05) between the two LongSAGE libraries ( Figure 2 and Table 4 ). Long-SAGE tags statistically (p ≤ 0.001) differentially represented between the libraries were enriched in the higher abundance classes compared to the lower abundance classes (Table 2) . Additionally, 90% of the LongSAGE tags were statistically (p ≤ 0.001) differentially represented between the libraries with ≥ 2-fold differences, compared to only 17% of tags with p-values greater than 0.001 (p > 0.001).
A stringent p-value cutoff (p ≤ 0.001), not corrected for multiple tests, was employed prior to validation of changes in expression of a gene in response to androgen. LongSAGE tags that were differentially expressed, but mapped ambiguously to more than one gene, and/or dif-fered by less than 2-fold between the treatment groups, were excluded from analysis. Application of these criteria reduced the LongSAGE tags from 131 to 93. These 93 tags represented 87 genes. Analysis of differentially expressed LongSAGE tags revealed that 54 LongSAGE tags that mapped to 52 genes were previously known to change in expression in the direction observed in response to androgen in prostate cancer cells. Of these, the expression of 41 genes increased as expected, including the well-known androgen-regulated gene, KLK3 ( Table 5 ). The expression of 11 genes decreased in response to androgen and were consistent with previous reports ( Table 6 ). Genes previously not reported to alter expression in response to androgen in prostate cancer cells were represented by 39 LongSAGE tags. These tags represented the expression of 20 genes that were increased, excluding mappings to noncoding and intergenic regions, (Table 7) , and expression of 15 genes that was decreased (Table 8 ) in response to androgen. The 93 tags were represented by 87 genes because one tag did not map to the human genome (Table  7) and two tags mapped to intergenic regions of the human mitochondrial genome (Tables 7 and 8 ). Three genes were represented twice in the tables (CAMK2N1, PPAP2A, and SORD). One gene, KRT8, was categorized in both the known and not previously known categories due to the sense of the mapping (Tables 5 and 8 ).
Interestingly some antisense tags were identified as differentially expressed in response to androgen. Antisense to NKX3-1 is of particular note. Transcription of this gene is (Continued) enhancer region [42] . Anti-sense RNA is involved in transcriptional silencing of sense transcript, imprinting control, post-transcriptional down-regulation of sense transcript or even stabilizing/promotion of the expression of the sense transcript [43] . In the case of NKX3-1, antisense transcript may be a negative feedback mechanism; however, this remains to be determined.
Relationship between LongSAGE library compositions
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Validation of changes in gene expression in response to androgen
Quantitative real time-polymerase chain reaction (qRT-PCR) was used to validate changes in gene expression in response to androgen of 39 (13 known; 26 novel) of the 87 total genes identified by LongSAGE. Of the 35 genes previously not reported to change expression in response to androgens in prostate cancer cells, only 26 were quantified by qRT-PCR, because technical limitations and gaps in the transcriptome databases prevented the analysis of 9 genes. That is, specific qRT-PCR primers could not be designed due to repetition in the genome, or because the tag mapped to an unannotated transcript variant. There were 24 of the 26 (92%) novel genes that displayed statistically significant differential expression in response to androgen as measured by qRT-PCR ( Figure 3A) . BLVRB, C19orf48, C1orf122, ERRFI1, GLUL, GOLPH3, HM13, HSP90B1, NANS, SLC41A1, TAOK3, TCP1, TMEM66, and USP33 all increased levels of expression in response to androgen, while ARL6IP5, C6orf66, CAMK2N1, CCNI, DERA, MANEA, NIPSNAP3A, SOD1, SVIP, and VTA1 decreased in response to androgen ( Figure 3A ). Under the experimental conditions and primers used, we did not measure statistically significant changes in expression of PRNPIP and CAPNS1. A false discovery rate (FDR) [44] of 29% was expected of the LongSAGE data based on the Audic and Claverie p-value ≤ 0.001. This FDR represents the anticipated percentage of type I errors (i.e., false positives). We observed only 2/26 (8%) false positives, suggesting that the other filter parameters (e.g., ≥ 2-fold difference in expression level) may have the increased the chances of validation by qRT-PCR. Moreover, the expression trends for all 13 genes known to change expression in response to androgen in prostate cancer cells correlated between the LongSAGE and qRT-PCR data. ADAMTS1, CENPN, CREB3L4, FKBP5, KLK3, LRIG1, NCAPD3, PAK1IP1, and RHOU all increased levels of expression in response to androgen while CXCR7, NTS, PRKACB, and ST7 decreased in response to androgen ( Figure 3B ).
Known or potential AREs in the regulatory regions of androgen-regulated genes
AR directly regulates transcription in response to androgen by binding to AREs in the promoter and/or enhancer regions of target genes. ChIP-chip database mining for suggested AREs combined with a literature search for known AREs revealed some of the genes that alter expression in response to androgen do contain AREs (Table 9) . For the 87 genes identified using the cut-off p-value of 0.001 and 2-fold change in response to androgen, there were eight genes with AREs in their promoter, enhancer or intron regions [16, 42, [45] [46] [47] [48] [49] . AREs were detected in the proximity of seven genes by data mining of ChIP-chip studies of ARE on chromosomes 19, 20, 21, 22 [50,51] .
Additionally, sequence analysis of the promoters [52] found eight genes from our gene list to contain potential AREs ( Table 9 ). Identification of potential AREs in the regulatory regions of the newly identified genes that alter expression in response to androgen (BLVRB, C19orf48, HM13, SOD1) may be directly regulated by AR.
Cell-type specificity of gene expression
To determine if expression of candidate genes was unique to LNCaP cells, we assayed for constitutive levels of expression of 18 known and novel candidate genes in prostate cancer cell lines DU145 [53] and PC-3 [54] using qRT-PCR ( Figure 4 ). Genes chosen included those that both increased (ADAMTS1, CAPNS1, CENPN, CREB3L4,  ERRFI1, FKBP5, HSP90B1, KLK3, LRIG1, NCAPD3 , PAK1IP1, and TAOK3) and decreased expression in response to androgen (ARL6IP5, CAMK2N1, CCNI, CXCR7, PRKACB and ST7). No obvious trends were observed depending on whether expression of the genes increased, or decreased, in response to androgen. All genes tested, except ERRFI1, were expressed at a lower level in PC-3 and DU145 cells relative to LNCaP cells. This suggests that the majority of genes that alter levels of expression in response to androgen were enriched in LNCaP cells relative to PC-3 and DU145 cells. These data are consistent with both DU145 and PC3 cells being androgen-insensitive and lacking a functional AR [53, 54] .
In vivo changes in gene expression in response to androgen-deprivation
The LNCaP Hollow Fibre model combined with qRT-PCR was employed to capture in vivo gene expression representative of physiological levels and castrated levels of androgen ( Figure 5 ). We expected that the genes that had increased levels of expression in vitro in response to androgens, would decrease expression in vivo in response to castration (androgen-deprivation). Conversely, we expected that the genes that had decreased levels of expression in vitro in response to androgens, would increase expression in vivo in response to castration. These in vivo results would be consistent with androgen-responsiveness of the candidate genes. Of the candidate genes examined, 13 of 16 genes showed significant changes in gene expression in response to androgen-deprivation ( Figure 5 ). As anticipated, expression of ARL6IP5, CAMK2N1, CXCR7, and ST7 increased, while CENPN, CREB3L4, ERRFI1, FKBP5, KLK3, LRIG1, NCAPD3, PAK1IP1, and TAOK3 decreased a Statistics according to the Audic and Claverie test statistic (p ≤ 0.001) b ND, not detected c ND tags were assigned a value of 1 when calculating fold change d Appropriate significant figures are displayed e Gene family, but not this family member, previously described to change expression in response to androgens g Protein known to change expression in reponse to androgens h Gene known to change expression in response to androgens, but in the opposite direction as reported here i Gene known to change expression in response to androgens in cells other than prostate k Tag has a single base pair mutation, insertion, or deletion with respect to gene map mTag maps to the strand opposite of the gene n Ambiguously mapped tags and tags with a fold change less than 2-fold have been excluded from the table p NC_001807, refers to the complete genome of mitochondria in humans All mitochondrial genes in the RefSeq database are assigned the same accession number by NCBI q N/A, there is no HGNC approved gene symbol or description for this tag t Tag count per 100,000 = (observed tag count/total tags in the library) × 100,000 φ In cases where a tag mapped to >1 transcript variant of the same gene the RefSeq accession number for transcript variant 1 was displayed * Gene further characterized in this paper h Gene known to change expression in response to androgens, but in the opposite direction as reported here i Gene known to change expression in response to androgens in cells other than prostate j Negative fold change value indicates down-regulation by R1881 k Tag has a single base pair permutation, insertion, or deletion with respect to gene mTag maps to the strand opposite of the gene n Ambiguously mapped tags and tags with a fold change less than 2-fold have been excluded from the table p NC_001807 refers to the complete genome of mitochondria in humans All mitochondrial genes in the RefSeq database are assigned the same accession number by NCBI q N/A = there is no HGNC approved gene symbol for this tag t Tag count per 100,000 = (observed tag count/total tags in the library) × 100,000 φ In cases where a tag mapped to >1 transcript variant of the same gene the RefSeq accession number for transcript variant 1 was displayed * Gene further characterized in this paper levels of expression in response to castration. No significant changes in gene expression in vivo was measured for ADAMTS1, HSP90B1, or PRKACB, suggesting that in vivo, other factors may influence their expression. Alternatively, the expression kinetics of each specific gene and half-life of its transcript may vary considerably. The time of harvesting samples and measuring changes in expression of genes in response to androgen-deprivation was at 10 days in vivo compared to 16 hr in vitro in response to addition of androgens (10 nM R1881). Different levels of androgen may also have profound effects on proliferation and dif-ferentiation. Physiological levels of androgen in male Nude mice may be considerably lower than the levels used in vitro. Androgen at 10 nM inhibits proliferation of LNCaP cells in vitro while 0.1 nM is optimal for proliferation [55] .
Conclusion
Androgens are essential for the growth, development and maintenance of the prostate. Here, we created LongSAGE libraries to obtain quantitative gene expression profiles of LNCaP human prostate cancer cells treated with, or with-Androgen regulation of genes as measured by qRT-PCR out, androgen and revealed the following: 1) 33,385 tag types in the R1881 LongSAGE library and 31,764 tag types in the vehicle LongSAGE library; 2) the majority (64% to 67%) of tag types in each LongSAGE library were singletons which may represent very low abundance transcripts (≤ 5 transcript copies per cell); 3); when mapped tags were clustered and ambiguous mappings were removed, the tag types in the R1881 and vehicle LongSAGE libraries represented 7,484 genes and 7,441 genes, respectively; 4) 53% of tags mapped solely to known exons, 9% solely to known introns (novel transcript variants), and 38% to intergenic regions (novel genes or transcript variants); 5) the most highly abundant LongSAGE tag mapped to human mitochondrial NADH ubiquinone oxidoreduct-ase chain 4 involved in metabolic energy; 6) the lower abundance classes were enriched for genes with functions in regulating transcription; 7) 87 genes were differentially expressed by two-fold (p ≤ 0.001) in response to androgen representing 0.34% of the total tag types (131 differentially expressed tag types/38,574 total tag types); 8) some of these genes have confirmed or potential AREs; 9) novel androgen regulated genes (direct or indirect) identified and validated were ARL6IP5, BLVRB, C19orf48, C1orf122, C6orf66, CAMK2N1, CCNI, DERA, ERRFI1, GLUL, GOLPH3, HM13, HSP90B1, MANEA, NANS, NIPSNAP3A, SLC41A1, SOD1, SVIP, TAOK3, TCP1, TMEM66, USP33, and VTA1; 9) expression of ADAMTS1, ARL6IP5, CAMK2N1, CAPNS1, CENPN, CREB3L4, CCNI, CXCR7, FKBP5, HSP90B1, KLK3, LRIG1, NCAPD3, PAK1IP1, PRKACB, ST7, and TAOK3 was increased in LNCaP cells compared to prostate cancer cells lacking a functional AR; and 10) significant differences in levels of expression of ARL6IP5, CAMK2N1, CENPN, CREB3L4, CXCR7, ERRFI1, FKBP5, KLK3, LRIG1, NCAPD3, PAK1IP1, ST7, and TAOK3 were measured in vivo in response to androgen-deprivation. The products of these genes are involved in amino acid and protein synthesis, cofactor transport, protein trafficking, response to oxidative stress, as well as signaling pathways that regulate gene expression, proliferation, apoptosis, and differentiation.
These genes are potentially critical for the function and maintenance of the prostate and represent targets for clinical intervention. 
Methods
Cell culture
